Publications by authors named "Erica D Warlick"

34Publications

Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis.

Biol Blood Marrow Transplant 2020 Jun 12;26(6):e138-e141. Epub 2020 Mar 12.

BMT & Cellular Therapy Program, Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.003DOI Listing
June 2020

Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.

Biol Blood Marrow Transplant 2020 02 24;26(2):272-277. Epub 2019 Oct 24.

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.013DOI Listing
February 2020

Multiple transmissions of chromosomally integrated human herpesvirus-6 in one family.

Transpl Infect Dis 2018 Feb 16;20(1). Epub 2018 Jan 16.

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.12816DOI Listing
February 2018

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.

Ann Hematol 2015 Oct 11;94(10):1667-75. Epub 2015 Jun 11.

Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, 420 Delaware Street SE; MMC 484, Minneapolis, MN, 55455, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-015-2422-z
Publisher Site
http://dx.doi.org/10.1007/s00277-015-2422-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725732PMC
October 2015

Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.

Cancer Epidemiol 2015 Apr 18;39(2):222-8. Epub 2015 Feb 18.

Hematology, Oncology and Transplantation, University of Minnesota, MMC 480, 420 Delaware Street SE, Minneapolis, MN 55455, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2015.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361261PMC
April 2015

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

Biol Blood Marrow Transplant 2015 Feb 6;21(2):357-63. Epub 2014 Nov 6.

Service d'Hematologie Greffe, Hôpital Saint-Louis, AP-HP, Paris, France; INSERM (Institut national de la santé et de la recherche médicale), UMR1160 (Unité mixte de recherche 1160 - Alloimmunité - Autoimmunité - Transplantation), Hôpital Saint- Louis, AP-HP, Paris, France; Université Paris VII Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736537PMC
February 2015

Myelodysplastic syndromes: the role of the immune system in pathogenesis.

Leuk Lymphoma 2011 Nov 12;52(11):2045-9. Epub 2011 Jun 12.

Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2011.58
Publisher Site
http://dx.doi.org/10.3109/10428194.2011.584002DOI Listing
November 2011

To cry or not to cry: physicians and emotions at the bedside.

Minn Med 2011 Jan;94(1):40-2

Division of Hematology, Oncology, and Transplantation, University of Minnesota, USA.

View Article

Download full-text PDF

Source
January 2011

Epidemiology of myelodysplastic syndromes: many questions remain.

Authors:
Erica D Warlick

Leuk Lymphoma 2011 Feb;52(2):163-4

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.551021DOI Listing
February 2011

Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.

Leuk Res 2011 Jun 12;35(6):757-61. Epub 2011 Jan 12.

Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.12.013DOI Listing
June 2011

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine.

Onco Targets Ther 2010 Sep 7;3:157-65. Epub 2010 Sep 7.

Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939768PMC
http://dx.doi.org/10.2147/ott.s5852DOI Listing
September 2010

Optimizing stem cell transplantation in myelodysplastic syndromes: unresolved questions.

Authors:
Erica D Warlick

Curr Opin Oncol 2010 Mar;22(2):150-4

Division of Hematology, Oncology, and Transplant, University of Minnesota, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328335a543DOI Listing
March 2010

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Biol Blood Marrow Transplant 2009 Jan;15(1):30-8

Blood and Marrow Transplant Program, Departments of Medicine and Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.10.012DOI Listing
January 2009